Current trends and perspectives of bioactive peptides

ABSTRACT

The remarkable growth of therapeutic peptide development in the past decade has led to a large number of market approvals and the market value is expected to hit $25 billion by 2018. This significant market increase is driven by the increasing incidences of metabolic and cardiovascular diseases and technological advancements in peptide synthesis. For this reason, the search for bioactive peptides has also increased exponentially. Many bioactive peptides from food and nonfood sources have shown positive health effects yet, obstacles such as the need to implement efficient and cost-effective strategies for industrial scale production, good manufacturing practices as well as well-designed clinical trials to provide robust evidence for supporting health claims continue to exist. Several other factors such as the possibility of allergenicity, toxicity and the stability of biological functions of the peptides during gastrointestinal digestion would need to be addressed.

KEYWORDS:

• Therapeutic peptides
• in vivo tests
• antimicrobial peptides
• functional foods

Conflict of interest

The authors declare that they have no conflict of interest.

Acknowledgments

This work was funded by a grant from Kangwon National University in 2015.